These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2257351)

  • 21. Scar size and effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of tuberculosis and leprosy: a case-control study.
    Zodpey SP; Shrikhande SN; Kulkarni SW; Maldhure BR
    Indian J Public Health; 2007; 51(3):184-9. PubMed ID: 18229442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunotherapy and immunoprophylaxis of leprosy.
    Convit J; Ulrich M
    Indian J Lepr; 2000; 72(1):21-32. PubMed ID: 10935184
    [No Abstract]   [Full Text] [Related]  

  • 23. Vaccination and skin test studies on the children of leprosy patients.
    Stanford JL; Stanford CA; Ghazi Saidi K; Dowlati Y; Weiss SF; Farshchi Y; Madlener F; Rees RJ
    Int J Lepr Other Mycobact Dis; 1989 Mar; 57(1):38-44. PubMed ID: 2659700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mycobacterial disease--old problems, new solutions.
    Collins CH; Grange JM
    Soc Appl Bacteriol Symp Ser; 1996; 25():viiS-viiiS. PubMed ID: 8972113
    [No Abstract]   [Full Text] [Related]  

  • 25. Modern vaccines. Mycobacterial diseases.
    Fine PE; Rodrigues LC
    Lancet; 1990 Apr; 335(8696):1016-20. PubMed ID: 1970071
    [No Abstract]   [Full Text] [Related]  

  • 26. [Protective properties of M. lufu in experimental leprosy].
    Iushin MIu; Kalianina OV
    Probl Tuberk; 1995; (2):47-8. PubMed ID: 7777465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunoprophylaxis of leprosy--lessons from the TB program.
    Young D
    Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4 Suppl):S75-6. PubMed ID: 9030131
    [No Abstract]   [Full Text] [Related]  

  • 28. Association of HLA antigens with differential responsiveness to Mycobacterium w vaccine in multibacillary leprosy patients.
    Rani R; Zaheer SA; Suresh NR; Walia R; Parida SK; Mukherjee A; Mukherjee R; Talwar GP
    J Clin Immunol; 1992 Jan; 12(1):50-5. PubMed ID: 1551942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunological tools in leprosy control.
    Fine PE
    Int J Lepr Other Mycobact Dis; 1989 Sep; 57(3):671-86. PubMed ID: 2674305
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparative study of immunizing and delayed hypersensitivity eliciting antigens of Mycobacterium leprae, M. tuberculosis, M. vaccae, and M. bovis (BCG).
    Sinha S; Sreevatsa ; Gupta SK; Sengupta U
    Int J Lepr Other Mycobact Dis; 1987 Mar; 55(1):42-53. PubMed ID: 2435824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential of Mw as a prophylactic vaccine against pulmonary tuberculosis.
    Katoch K; Singh P; Adhikari T; Benara SK; Singh HB; Chauhan DS; Sharma VD; Lavania M; Sachan AS; Katoch VM
    Vaccine; 2008 Feb; 26(9):1228-34. PubMed ID: 18243430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis.
    Sun R; Skeiky YA; Izzo A; Dheenadhayalan V; Imam Z; Penn E; Stagliano K; Haddock S; Mueller S; Fulkerson J; Scanga C; Grover A; Derrick SC; Morris S; Hone DM; Horwitz MA; Kaufmann SH; Sadoff JC
    Vaccine; 2009 Jul; 27(33):4412-23. PubMed ID: 19500523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The BCG trials.
    Stanford JL
    Practitioner; 1983 Feb; 227(1376):x-xiii. PubMed ID: 6346314
    [No Abstract]   [Full Text] [Related]  

  • 34. [A new vaccine strain: MPH (Murine Praha Homogeneous), developed from Mycobacterium microti OV 247 (Wells)].
    Sula I
    Tuberkuloza; 1966; 18(1-3):275-8. PubMed ID: 16296096
    [No Abstract]   [Full Text] [Related]  

  • 35. Mycobacterial antibodies after tuberculin testing, BCG- vaccination, BCG-immunotherapy and against cross-reacting antigens in a solid-phase radioimmunoassay.
    Mauch H; Brehmer W
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Mar; 251(3):380-8. PubMed ID: 6805156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens.
    Brodin P; Majlessi L; Brosch R; Smith D; Bancroft G; Clark S; Williams A; Leclerc C; Cole ST
    J Infect Dis; 2004 Jul; 190(1):115-22. PubMed ID: 15195250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Vaccination against leprosy].
    Grosset J; Lecoeur H
    Acta Leprol; 1986; 4(3):289-91. PubMed ID: 3551467
    [No Abstract]   [Full Text] [Related]  

  • 38. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative experimental study of sensitivity to tuberculin and lepromin in guinea-pigs previously inoculated with BCG by oral and intradermal routes.
    Azulay RD; Kahn I
    Int J Lepr Other Mycobact Dis; 1970; 38(4):373-8. PubMed ID: 5534492
    [No Abstract]   [Full Text] [Related]  

  • 40. Human leukocyte antigens in tuberculosis and leprosy.
    Meyer CG; May J; Stark K
    Trends Microbiol; 1998 Apr; 6(4):148-54. PubMed ID: 9587192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.